DENVER – Even as prescribing of tumor necrosis factor inhibitors for patients with ankylosing spondylitis climbed in the last half-dozen years, patients’ use of prescription narcotics increased as...
DENVER – Recreational exercise and tumor necrosis factor–inhibitor therapy provide synergistic improvement in the functional status of patients with ankylosing spondylitis, according to an analysis...
DENVER – The emerging new era in the treatment of spondyloarthritis is combined blockade of tumor necrosis factor–alpha (TNF-alpha) and interleukin-17 using a bispecific antibody, Dr. Siba P....
The oral Janus kinase inhibitor tofacitinib was effective at treating rheumatoid arthritis in patients who had never before taken or had an inadequate response to biological disease-modifying...
Long-term remission of rheumatoid arthritis for 24 weeks allowed 58%-73% of patients to regain full physical function, depending on which disease activity index is used, researchers reported online...
DENVER – Spondyloarthritis experts have zeroed in on a simple and effective screening and referral strategy for nonrheumatologists to use in deciding which patients with chronic low back pain to send...
Oral contraceptive use may improve symptoms of inflammatory arthritis in women, according to a cohort study conducted in Germany between 2010 and 2013.
The researchers analyzed reports on 273 18- to...
Patients with moderately active rheumatoid arthritis who were positive for rheumatoid factor and had baseline C-reactive protein levels above 40 mg/L had about a 60% chance of progressing on...
Tuberculosis is the only condition in patients with psoriasis or psoriatic arthritis who are being treated with systemic biologic agents for which there is strong evidence in favor of baseline...
Researchers have uncovered a bidirectional relationship between psoriatic disease – psoriasis and psoriatic arthritis – and uveitis, with either condition significantly increasing the risk of the...
